Clinical Trials Directory

Trials / Unknown

UnknownNCT00467129

Genes That Affect Disease Outcome in Patients With Metastatic Colorectal Cancer

The Role of Genetic Factors in Clinical Outcome for Colorectal Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
800 (estimated)
Sponsor
University of Sheffield · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

RATIONALE: Studying samples of blood and tumor tissue in the laboratory from patients with cancer may help doctors learn more about changes that occur in DNA and help doctors understand how patients respond to treatment. PURPOSE: This clinical trial is examining genes that affect disease outcome in patients with metastatic colorectal cancer.

Detailed description

OBJECTIVES: * Collect blood samples for DNA extraction for genetic studies from patients receiving chemotherapy for metastatic colorectal cancer. * Collect detailed clinical, pathological, and chemotherapy data from these patients. * Identify genetic factors that relate to treatment response and outcome in these patients. OUTLINE: Blood samples are collected and relevant genes and regions are amplified by PCR. PCR products are then sequenced or genotyped for known biological markers and single nucleotide polymorphisms. Tumor samples from surplus pathology specimens are analyzed for expression of candidate genes and mutation in the candidate genes. Clinical and family history data is also collected by questionnaire. PROJECTED ACCRUAL: A total of 800 patients will be accrued for this study.

Conditions

Interventions

TypeNameDescription
GENETICmicroarray analysis
GENETICmutation analysis
GENETICpolymerase chain reaction
GENETICpolymorphism analysis
OTHERlaboratory biomarker analysis
OTHERquestionnaire administration

Timeline

Start date
2002-07-01
First posted
2007-04-27
Last updated
2013-12-18

Source: ClinicalTrials.gov record NCT00467129. Inclusion in this directory is not an endorsement.